12 Best Online GLP-1 Programs in 2026

Best online GLP-1 programs compared: which one fits you

Every program here uses a licensed prescriber and a US pharmacy. Most send compounded medicine. That means a pharmacy makes it from the same active ingredient, but it is not an FDA-approved brand. Start with the line that sounds like you:

• Best overall: Mochi Health, for both medicines in all 50 states, from about $140 a month.
• Lowest price, if you can prepay six months: Nu Image Medical, about $90 a month for either medicine. All sales are final, and plans renew on their own.
• Low price on a prepaid year: BetterMe Rx or Arbor, from about $100 a month on a 12-month plan. Neither refunds a prepaid year once the order is under way.
• No membership, with a pill option: Henry Meds, from about $200 a month on its 12-month prepay.
• Brand-name drugs with a lab test and insurance help: Ro Body.
• Brand-name drugs only, including the newest pills: Hers.
• Coaching and a dietitian in the price: Fridays.
• Commercial insurance that pays for visits: Found, from about $100 a month for semaglutide on a 12-month plan, plus a visit copay.
• Lowest price without a prepay: Eden, about $100 a month for semaglutide or $130 for tirzepatide.
• You already use Noom's app: Noom Med.
• No membership fee and LegitScript certification, in 36 states: Willow.

Mochi Health: our best overall pick

Mochi Health is a large GLP-1 telehealth platform, with more than 500,000 members. Its doctors include specialists board-certified in obesity medicine, a specialty focused on weight care. It prescribes in all 50 states.

Since August 2026, the medicine price rises with your dose. The $79 monthly membership comes on top. Here is what you pay each month, all-in:

• Semaglutide: about $140 a month at the starting dose, up to about $270.
• Tirzepatide: about $170 a month at the starting dose, up to about $280.
• First month: new members pay nothing for the membership right now. Month one starts at about $60 for semaglutide. The offer is not available in every state.

Semaglutide comes as a weekly shot or a weekly pill, and there is a microdosing plan. The membership covers messaging, video visits with doctors and dietitians, and dose management. It can also cover menopause hormone therapy, which few weight programs offer.

• Pros: low entry price; a free first month of membership for new members; obesity-medicine doctors; all 50 states; several semaglutide formats; hormone therapy on the same membership.
• Cons: the price rises with the dose; labs are not included. Its former pharmacy partner, Aequita, was shut down by Washington State in March 2025, so ask which pharmacy fills yours.

Henry Meds: no membership, and a pill option

Henry Meds charges one bundled price with no membership on top. The visit, medicine and supplies are all included.

The price depends on the medicine, the form and how long you prepay:

• Semaglutide shot: about $300 a month. It drops to about $250 on a 6-month prepay, or about $200 on a 12-month prepay.
• Semaglutide pill: about $250 a month.
• Tirzepatide: about $350 a month as a pill, or about $450 as a shot.

Henry says the price varies with your plan and dose. Ask what your maintenance dose will cost before you prepay.

Henry Meds serves about 40 states plus DC. It treats adults aged 18 to 70. Everything happens online. Most people get their medicine 8 to 10 business days after the visit.

• Pros: no membership fee; pill or shot for both medicines; good price on the 12-month prepay.
• Cons: not available in about 10 states; compounded only, in a shifting legal setting.

BetterMe Rx: among the lowest prices on a 12-month plan

BetterMe Rx has among the lowest 12-month prices we track. On that plan, you pay for the whole year in one charge.

• Semaglutide: about $100 a month on the 12-month plan, or about $1,190 upfront. About $200 month to month.
• Tirzepatide: about $160 a month on the 12-month plan, or about $1,910 upfront. About $250 month to month.

The price stays the same at every dose. Visits and shipping are included. Its FAQ names the doctor networks that prescribe and seven US pharmacies that fill the orders.

The low price comes with a strict policy. Once an order is processed, nothing is refunded. That includes the unused months of a prepaid plan. Reviews are mixed, at 3.6 out of 5 on Trustpilot. The site does not publish the company's legal name. It also sells tirzepatide tablets, which have no clinical evidence behind them.

• Pros: among the lowest 12-month prices for both medicines; same price at every dose; named doctor networks and pharmacies.
• Cons: no refunds once an order is processed; mixed reviews, with complaints about leaking vials and slow support; compounded only.

Arbor: a low yearly price, with a dietitian included

Arbor, formerly Harbor, sells compounded semaglutide and tirzepatide as weekly shots. Its partner medical group, MD Integrations, handles the doctor visits. A registered dietitian is included, also for when you come off the medicine.

• Semaglutide: $99/mo on a 12-month plan, charged once as $1,188 · $149 month to month
• Tirzepatide: $149/mo on a 12-month plan, charged once as $1,788 · $249 month to month
• Included: visits, check-ins, shipping and a dietitian, the same price at every dose

The refund rules are strict. Once a prescription is written, nothing is refunded, including months not yet shipped. Its 12-month money-back guarantee excludes anyone who took a weight-loss drug in the year before. It does not name its pharmacies. Trustpilot rates it 4.5 out of 5, on only 51 reviews under its old Harbor name.

• Pros: among the lowest 12-month prices for both medicines; same price at every dose; named medical group; dietitian included.
• Cons: the low price needs a year upfront; no refunds once a prescription is written; pharmacies not named; a small review record.

Nu Image Medical: the lowest price, on a 6-month prepay

Nu Image Medical is a Tampa telehealth clinic, founded in 2004 and online since 2008. It sells compounded semaglutide and tirzepatide as weekly shots or as tablets that dissolve under the tongue. A physician-owned medical group prescribes, and its terms name the four pharmacies that fill the orders.

• Semaglutide or tirzepatide shot: $89/mo on a 6-month plan, billed every six months · $199/mo on 3 months · $299 month to month
• Tablets: from about $270 a month, three times the price of the shot
• Included: shipping, the same price at every dose

The billing rules are strict. All sales are final, and plans renew on their own until you cancel, at least 48 hours before the renewal date. Most complaints filed with the Better Business Bureau are about those renewals and refunds. Trustpilot rates it 4.4 out of 5, on about 1,000 reviews.

• Pros: the lowest price we track for both medicines; same price at every dose; a long record; named prescribers and pharmacies.
• Cons: the low price needs six months paid at once; about $300 month to month; no refunds; auto-renew complaints; the tablets cost far more and are less proven.

Ro Body: best for brand-name drugs with a lab test and insurance help

Ro stopped offering compounded GLP-1s in 2026. It now prescribes only FDA-approved brands: Wegovy as a pen or pill, Ozempic, Zepbound and Foundayo, a newer daily GLP-1 pill. So you know exactly who made your medicine. The trade-off is cost.

The Ro Body membership costs $149 a month, with a $39 first month. Prepaying drops it to between $74 and $99 a month. It covers provider visits, messaging and insurance help. It also covers a metabolic lab test at Quest when your provider orders one. The medicine is extra, at these cash prices:

• Wegovy pill: $149 a month at the starting dose, up to $299 at the top doses.
• Wegovy pen: $199 a month for your first two fills if you sign up by Dec 31, 2026. After that, $349.
• Zepbound: $299 a month at the starting dose, up to $449. The $449 price needs a refill within 45 days. Otherwise it costs $499–$699.

Ro's insurance team handles prior authorization, the approval step your insurer may require before it pays. That matters because brand-name drugs have a real shot at coverage.

• Pros: FDA-approved brands only; a lab test in the membership; insurance help; two needle-free pills.
• Cons: the most expensive option for cash payers; the medicine is billed on top of the membership; no compounded option.

Eden: the lowest price without a prepay

Eden keeps things simple: an online intake, a provider review, and a prescription sent to a compounding pharmacy. There is no membership and no prepay.

Semaglutide costs about $100 a month, all in. Tirzepatide costs about $130. The price is the same at every dose and every month. Eden fills prescriptions at its own pharmacy in New Mexico or at partner pharmacies, which make each drug for one patient.

• Pros: lowest price here without a prepay; same price at every dose; simple intake.
• Cons: less clinical depth than Mochi or Fridays; FDA warning letter in June 2026; BBB rating of F.

Fridays: best for coaching built into the price

Fridays bundles more support into its price than most. Provider visits, one-on-one dietitian coaching, group coaching and a fitness app are all included, with no membership fee.

If you want accountability alongside the medicine, it is one of the most complete packages here. Here is what the compounded medicine costs:

• Semaglutide: about $280 a month, or about $150 a month on the annual plan.
• Tirzepatide: about $390 a month, or about $240 a month on the annual plan.
• Fall sale: codes on its pricing page bring the annual plan down to about $115 for semaglutide or about $200 for tirzepatide.

• Pros: dietitian coaching and fitness app included; microdosing available; tirzepatide option.
• Cons: month-to-month prices are higher than some rivals; the lowest price needs a year upfront; a BBB rating of F, mostly over refund complaints left unanswered.

Found: a lower price when insurance pays for your visits

Found is an online weight clinic with a wide menu. It offers compounded semaglutide and tirzepatide, brand-name drugs such as Wegovy and Zepbound, and non-GLP-1 pills such as metformin.

Compounded plans are all-in: care, medicine and membership in one price, the same at every dose. You pay less on a longer plan, and less again if commercial insurance pays for your visits.

• Semaglutide, cash: about $290 a month, or about $170 a month on a 12-month plan paid up front.
• Tirzepatide, cash: about $360 a month, or about $240 a month on a 12-month plan.
• With commercial insurance: semaglutide about $100 to $200 a month, tirzepatide about $180 to $290. You see a clinician by video before each refill and pay a copay, about $30.

The insurance prices do not apply to Medicare, Medicaid or TRICARE. The membership fee is refundable only within 3 days, or before your first visit. Trustpilot rates Found 4.2 out of 5 on about 750 reviews, and most complaints are about billing and slow support. More in our Found review.

• Pros: compounded and brand-name drugs in one place; same price at every dose; insurance lowers the plan price; help with the Medicare GLP-1 Bridge.
• Cons: the low cash price needs a year paid up front; month to month it costs more than most programs here; a visit copay before each refill with insurance; no hormone therapy.

Hers: brand-name drugs only

Hers is the women's health arm of Hims & Hers. After a March 2026 agreement with Novo Nordisk, it now leads with FDA-approved brands instead of compounded drugs.

A separate $149 monthly membership comes on top of the medicine, with a $39 first month. All-in, most women pay about $300 to $600 a month. The medicine costs:

• Wegovy pill: from $149 a month, rising with the dose.
• Wegovy pen: $199 a month for the first two fills, then $349.
• Zepbound vial or KwikPen: from $299 a month, rising with the dose.

Compounded semaglutide, the old pill kit and generic liraglutide no longer appear on the Hers storefront.

For a needle-free start, Hers also lists the Foundayo pill, a newer daily GLP-1 from Eli Lilly, from $149 a month. Hers does not take insurance, and labs are not included.

• Pros: a real range of FDA-approved brands at cash prices below retail; a low-cost non-GLP-1 option; clinician messaging and nutrition guidance.
• Cons: the membership is billed apart from the medicine and does not cancel with it; no labs; an FDA warning letter in September 2025 over its compounded semaglutide marketing.

Noom Med: best if you already use Noom's app

Noom built its name on the psychology of eating: triggers, tracking and habit tools. Noom Med adds GLP-1 medicine on top of that app.

Each plan has a lower price for the first 4 weeks. After that, Noom bills every 12 weeks, so you pay three months at once. Once a prescription is written, Noom does not refund the bill. The ongoing prices are:

• Microdose semaglutide: about $180 a month, after about $80 for the first 4 weeks. It suits women who want to start low or worry about side effects.
• Semaglutide: about $250 a month, after about $130 for the first 4 weeks.
• Tirzepatide: about $300 a month, after about $150 for the first 4 weeks.

• Pros: strong habit and tracking tools; a microdose option; tirzepatide available; one app if you already use Noom.
• Cons: you pay 12 weeks at a time, with no refund once a prescription is written; the full-dose plans are not the cheapest.

Willow: no membership fee and LegitScript certification, in 36 states

Willow charges one all-in monthly price, with no membership fee. Compounded semaglutide costs about $300 a month at every usual dose. Tirzepatide starts at about $400 and climbs to about $550 at the top dose.

Willow is LegitScript certified, a third-party check of online pharmacies and clinics. It publishes a US address in Texas and names its partner pharmacies. Those are the kinds of transparency signs worth checking on any platform.

The limit is reach. Willow works in only 36 states. It does not take insurance. You can pay from a health savings or flexible spending account, known as HSA and FSA.

• Pros: LegitScript certified; flat price at every dose; no membership fee; HSA and FSA accepted.
• Cons: only 36 states; costs more than Mochi, BetterMe or Eden for similar compounded medicine.

How to tell a legitimate GLP-1 program from a risky one

The FDA sent warning letters to dozens of telehealth and compounding sellers in September 2025. It sent 30 more in March 2026. The problems included calling compounded semaglutide "generic Ozempic" and implying it was FDA-approved. Some sellers also used salt forms, such as semaglutide sodium or acetate, which differ chemically from the approved drug.

Walk away if you see any of these signs:

• The intake is only a questionnaire, with no real provider review before the prescription.
• The pharmacy is not named, cannot show a certificate of analysis, or is outside the US.
• The company says "generic Wegovy," "same as Ozempic" or "FDA-approved compound." None of these is accurate.
• A month-to-month price far below $100 for injected semaglutide, with no named pharmacy behind it.
• No follow-up care, no help with dose changes, and no way to reach a clinician.

Which GLP-1 medications can you get online?

GLP-1 is a hormone your gut releases after you eat. GLP-1 medicines mimic it. They slow how fast your stomach empties and curb appetite, so eating less feels less like a fight. Two molecules dominate online care in 2026: semaglutide, the drug in Ozempic and Wegovy, and tirzepatide, the drug in Mounjaro and Zepbound.

The key difference is how they work. Semaglutide acts on one hormone target, GLP-1. Tirzepatide acts on two, GLP-1 and GIP. The SURMOUNT-5 trial compared them head to head and was published in the New England Journal of Medicine in 2025. Over 72 weeks, tirzepatide produced 20.2% average weight loss, against 13.7% for semaglutide.

A higher 7.2 mg semaglutide dose, approved in March 2026, has narrowed that gap. In its own trial, people on it lost about 20.7% of their weight, against 2.4% on placebo. The two have never been tested head to head at that dose. Tirzepatide usually costs more. Both often cause stomach side effects like nausea, mostly while the dose goes up. Our GLP-1 dosage guide shows how each dose steps up, which is when most prices rise.

Online programs may offer the brand-name drugs, compounded versions of the same molecules, or both. The legal ground for compounded GLP-1s shifted in 2025 and 2026. The FDA declared the tirzepatide shortage over in December 2024. It did the same for semaglutide in February 2025.

In April 2026 the FDA proposed keeping both molecules off the list that lets 503B outsourcing facilities make them in bulk. The public comment period closed on July 30, 2026, and a final decision is still to come. Pharmacies can still make them for one patient at a time when a prescriber documents a clinical reason. Mass-market supply, though, is shrinking.

Why midlife women have the most to gain from a GLP-1

Perimenopause and menopause speed up fat gain around the belly as estrogen falls. That deep belly fat, called visceral fat, raises the risk of heart disease and type 2 diabetes.

GLP-1 medicines work across menopause status. A 2025 analysis of the SURMOUNT trials found tirzepatide worked as well after menopause as before it. In one trial, postmenopausal women lost about 23% of their weight on tirzepatide, against 3% on placebo.

A Mayo Clinic study00145-1/abstract) in The Lancet Obstetrics, Gynaecology & Women's Health went further. Postmenopausal women on tirzepatide who also used hormone therapy lost about 19% of their weight. Women on tirzepatide alone lost about 14%. That is about 35% more weight loss with hormone therapy. The study was not randomized, so it cannot prove hormone therapy caused the gap. An earlier 2024 study in Menopause found the same pattern for semaglutide.

One theory is that estrogen makes the body more responsive to GLP-1. None of this means you need hormone therapy to benefit. Most women lose meaningful weight on the medicine alone. But if you use or are considering hormone therapy, mention this research to your prescriber.